Randomized phase III study of capecitabine, oxaliplatin, and bevacizumab with or without cetuximab in advanced colorectal cancer (ACC), the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG)

被引：59

作者：

Punt, C. J.

Tol, J.

Rodenburg, C. J.

Cats, A.

Creemers, G.

Schrama, J. G.

Erdkamp, F. L.

Vos, A.

Mol, L.

Antonini, N. F.

机构：

[1] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands

[2] Meander Med Ctr, Amersfoort, Netherlands

[3] Netherlands Canc Insitute, Amsterdam, Netherlands

[4] Catharina Hosp, Eindhoven, Netherlands

[5] Spaarne Hosp, Hoofddorp, Netherlands

[6] Maasland Hosp, Sittard, Netherlands

[7] Bernhoven Hosp, Oss, Netherlands

[8] Comprehens Canc Ctr E IKO, Nijmegen, Netherlands

[9] Netherlands Canc Inst, Amsterdam, Netherlands

来源：

关键词：

D O I：

10.1200/jco.2008.26.15_suppl.lba4011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA4011

引用

页数：1